Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study

Critical Care Medicine

Volumn 44, Issue 10, 2016, Pages 1842-1850

  Selvanderan, Shane P ^a   Summers, Matthew J ^b   Finnis, Mark E ^a,b   Plummer, Mark P ^a,b   Ali Abdelhamid, Yasmine ^b   Anderson, Michael B ^b   Chapman, Marianne J ^a,b,c   Rayner, Christopher K ^b,c,d   Deane, Adam M ^a,b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Clostridium difficile; critical illness; gastrointestinal diseases; gastrointestinal hemorrhage; pneumonia

Indexed keywords

HEMOGLOBIN; PANTOPRAZOLE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL OUTCOME; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG SCREENING; ENTERIC FEEDING; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXPLORATORY RESEARCH; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; PARALLEL DESIGN; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STRESS ULCER; VENTILATED PATIENT; VENTILATOR ASSOCIATED PNEUMONIA; AGED; CLOSTRIDIUM INFECTIONS; INTENSIVE CARE UNIT; KAPLAN MEIER METHOD; PNEUMONIA, VENTILATOR-ASSOCIATED; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; CLOSTRIDIUM INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PROSPECTIVE STUDIES;

EID: 84988434139     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001819     Document Type: Article

References (36)

1. Cook DJ, Griffith LE, Walter SD, et al: Canadian Critical Care Trials Group: The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001; 5: 368-375
2. Cook DJ, Fuller HD, Guyatt GH, et al: Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-381
3. Krag M, Perner A, Wetterslev J, et al: Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Intensive Care Med 2014; 40: 11-22
4. Krag M, Perner A, Wetterslev J, et al: SUP-ICU Co-Authors: Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med 2015; 41: 833-845
5. Plummer MP, Blaser AR, Deane AM: Stress ulceration: Prevalence, pathology and association with adverse outcomes. Crit Care 2014; 18: 213
6. Sim JA, Horowitz M, Summers MJ, et al: Mesenteric blood flow, glucose absorption and blood pressure responses to small intestinal glucose in critically ill patients older than 65 years. Intensive Care Med 2013; 39: 258-266
7. Marik PE, Vasu T, Hirani A, et al: Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis. Crit Care Med 2010; 38: 2222-2228
8. Metz CA, Livingston DH, Smith JS, et al: Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: A prospective, multicenter, double-blind, randomized trial. The Ranitidine Head Injury Study Group. Crit Care Med 1993; 21: 1844-1849
9. Martin LF, Booth FV, Karlstadt RG, et al: Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993; 21: 19-30
10. Vincent JL: Give your patient a fast hug (at least) once a day. Crit Care Med 2005; 33: 1225-1229
11. Dellinger RP, Levy MM, Rhodes A, et al: Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637
12. Eastwood GM, Litton E, Bellomo R, et al: Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units. Crit Care Resusc 2014; 16: 170-174
13. Kantorova I, Svoboda P, Scheer P, et al: Stress ulcer prophylaxis in critically ill patients: A randomized controlled trial. Hepatogastroenterology 2004; 51: 757-761
14. Powell H, Morgan M, Li SK, et al: Inhibition of gastric acid secretion in the intensive care unit after coronary artery bypass graft. A pilot control study of intravenous omeprazole by bolus and infusion, ranitidine and placebo. Theor Surg 1993; 8: 125-130
15. MacLaren R, Reynolds PM, Allen RR: Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med 2014; 174: 564-574
16. Buendgens L, Bruensing J, Matthes M, et al: Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J Crit Care 2014; 29: 696. e11-696. e15
17. Charlot M, Ahlehoff O, Norgaard ML, et al: Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: A nationwide cohort study. Ann Intern Med 2010; 153: 378-386
18. Laheij RJ, Sturkenboom MC, Hassing RJ, et al: Risk of communityacquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955-1960
19. Sankoh AJ, Huque MF, Dubey SD: Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997; 16: 2529-2542
20. Klompas M: Complications of mechanical ventilation-the CDC's new surveillance paradigm. N Engl J Med 2013; 368: 1472-1475
21. Davies AR, Morrison SS, Bailey MJ, et al: ENTERIC Study Investigators; ANZICS Clinical Trials Group: A multicenter, randomized controlled trial comparing early nasojejunal with nasogastric nutrition in critical illness. Crit Care Med 2012; 40: 2342-2348
22. McAuley DF, Laffey JG, O'Kane CM, et al: HARP-2 Investigators; Irish Critical Care Trials Group: Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371: 1695-1703
23. Deane AM, Wong GL, Horowitz M, et al: Randomized double-blind crossover study to determine the effects of erythromycin on small intestinal nutrient absorption and transit in the critically ill. Am J Clin Nutr 2012; 95: 1396-1402
24. Deane AM, Guyatt GH: Primum non nocere and challenging conventional treatment. Intensive Care Med 2015; 41: 933-935
25. Barletta JF, Kanji S, MacLaren R, et al: American-Canadian consortium for Intensive care Drug utilization (ACID) Investigators: Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada. J Crit Care 2014; 29: 955-960
26. Farley KJ, Barned KL, Crozier TM: Inappropriate continuation of stress ulcer prophylaxis beyond the intensive care setting. Crit Care Resusc 2013; 15: 147-151
27. Klompas M: Discordance between novel and traditional surveillance definitions for ventilator-associated pneumonia: Insights and opportunities to improve patient care. Infect Control Hosp Epidemiol 2014; 35: 1196-1198
28. Liu B, Liu S, Yin A, et al: Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: A systematic review and metaanalysis of randomized controlled trials. Crit Care 2015; 19: 409
29. Fossmark R, Johnsen G, Johanessen E, et al: Rebound acid hypersecretion after long-term inhibition of gastric acid secretion. Aliment Pharmacol Ther 2005; 21: 149-154
30. Reimer C, Søndergaard B, Hilsted L, et al: Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009; 137: 80-7, 87. e1
31. Yunos NM, Bellomo R, Bailey M: Chloride-restrictive fluid administration and incidence of acute kidney injury-reply. JAMA 2013; 309: 543-544
32. Young P, Bailey M, Beasley R, et al: Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: The SPLIT randomized clinical trial. JAMA 2015; 314: 1701-1710
33. Sackett DL: Why randomized controlled trials fail but needn't: 2. Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!). CMAJ 2001; 165: 1226-1237
34. Møller MH: Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU). Available at: https: //www. clinicaltrials. gov/ct2/show/ NCT02467621. Accessed January 8, 2016
35. Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis in ICU. Available at: https: //www. clinicaltrials. gov/ct2/show/study/NCT02290327. Accessed January 8, 2016
36. Litton E, Eastwood GM, Bellomo R, et al: A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data. Crit Care Resusc 2014; 16: 158-163